MOUNTAIN VALLEY MD HLDGS

Research MOUNTAIN VALLEY MD HLDGS (20MP) on Bullrun: market cap EUR 14.09M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 14.09M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CAD 57.00K-CAD 7.19M-CAD 2.32Mn/an/aCAD 316.00Kn/aCAD 466.00K

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-14EUR 14.09Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About MOUNTAIN VALLEY MD HLDGS

Mountain Valley MD Holdings Inc., a biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada. The company offers Quicksome which uses proprietary formulations and stabilizing agents to encapsulate active ingredients and optimizing delivery in pharmaceutical and nutraceutical applications; and Quicksol that enhances solubility for previously insoluble macrocyclic lactone drugs. It also provides licensed Agrarius, an agricultural plant signalling technology.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is MOUNTAIN VALLEY MD HLDGS's market cap?

MOUNTAIN VALLEY MD HLDGS's market capitalization is EUR 14.09M.

What does MOUNTAIN VALLEY MD HLDGS do?

Mountain Valley MD Holdings Inc., a biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada. The company offers Quicksome which uses proprietary formulations and stabilizing agents to encapsulate active ingredients and optimizing delivery in pharmaceutical and nutraceutical applications; and Quicksol that enhances solubility for previously insoluble macrocyclic lactone drugs. It also provides licensed Agrarius, an agricultural plant signalling technology. Mountain Valley MD Holdings Inc. is headquartered in Concord, Canada.